Versant Venture Capital Vi, L.p. - Net Worth and Insider Trading

Over the past 18 months, Versant Venture Capital Vi, L.p. made no insider transaction in Aligos Therapeutics Inc (ALGS). Other recent insider transactions involving Aligos Therapeutics Inc (ALGS) include a net purchase of 7,933,601 shares made by Carole Nuechterlein ,

In summary, during the past 3 months, insiders sold 0 shares of Aligos Therapeutics Inc (ALGS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aligos Therapeutics Inc (ALGS) were sold and 317,344 shares were bought by its insiders, resulting in a net purchase of 317,344 shares.

Aligos Therapeutics Inc (ALGS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital Vi, L.p. made 1 insider transaction in Black Diamond Therapeutics Inc (BDTX) with a net sale of 221,600. Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 221,600 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 221,600 shares. During the past 18 months, 246,600 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,075,850 shares were bought by its insiders, resulting in a net purchase of 4,829,250 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital Vi, L.p. made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .

In summary, during the past 3 months, insiders sold 0 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,163 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,978,847 shares.

Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital Vi, L.p. made no insider transaction in Passage Bio Inc (PASG). Other recent insider transactions involving Passage Bio Inc (PASG) include a net purchase of 953,146 shares made by Orbimed Advisors Llc , a net sale of 11,453 shares made by Simona King , and a net sale of 4,052 shares made by Alexandros Fotopoulos .

In summary, during the past 3 months, insiders sold 239,431 shares of Passage Bio Inc (PASG) in total and bought 0 shares, with a net sale of 239,431 shares. During the past 18 months, 258,044 shares of Passage Bio Inc (PASG) were sold and 1,192,577 shares were bought by its insiders, resulting in a net purchase of 934,533 shares.

Passage Bio Inc (PASG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital Vi, L.p. made no insider transaction in Akero Therapeutics Inc (AKRO). Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 171,998 shares made by Jonathan Young , a net sale of 443,502 shares made by Andrew Cheng , and a net sale of 140,584 shares made by Catriona Yale .

In summary, during the past 3 months, insiders sold 478,023 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 478,023 shares. During the past 18 months, 1,227,763 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net purchase of 92,237 shares.

Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Oyster Point Pharma Inc (OYST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oyster Point Pharma Inc (OYST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oyster Point Pharma Inc (OYST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital Vi, L.p. made 1 insider transaction in Tempest Therapeutics Inc (TPST) with a net sale of 787,999. Other recent insider transactions involving Tempest Therapeutics Inc (TPST) include a net purchase of 35,000 shares made by Stephen R Brady , a net purchase of 4,672 shares made by Samuel Whiting ,

In summary, during the past 3 months, insiders sold 787,999 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 787,999 shares. During the past 18 months, 787,999 shares of Tempest Therapeutics Inc (TPST) were sold and 39,672 shares were bought by its insiders, resulting in a net sale of 748,327 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Graphite Bio Inc (GRPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Graphite Bio Inc (GRPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Graphite Bio Inc (GRPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital Vi, L.p. made 3 insider transaction in Monte Rosa Therapeutics Inc (GLUE) with a net sale of 1,857,674. Other recent insider transactions involving Monte Rosa Therapeutics Inc (GLUE) include a net sale of 2,817 shares made by Edmund Dunn ,

In summary, during the past 3 months, insiders sold 1,857,674 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 0 shares, with a net sale of 1,857,674 shares. During the past 18 months, 1,860,491 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,860,491 shares.

Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital Vi, L.p. made no insider transaction in Century Therapeutics Inc (IPSC). Other recent insider transactions involving Century Therapeutics Inc (IPSC) include a net sale of 27,386 shares made by Gregory Russotti , a net sale of 59,805 shares made by Adrienne Farid , and a net sale of 1,746 shares made by Douglas Carr .

In summary, during the past 3 months, insiders sold 0 shares of Century Therapeutics Inc (IPSC) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 88,937 shares of Century Therapeutics Inc (IPSC) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 83,937 shares.

Century Therapeutics Inc (IPSC)'s detailed insider trading history can be found in Insider Trading Tracker table.